IGC Pharma, Inc.
US ˙ NYSEAM ˙ US45408X3089

Introduction

This page provides a comprehensive analysis of the known insider trading history of RANGA c KRISHNA. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate RANGA c KRISHNA has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:IGC / IGC Pharma, Inc. Director 1,068,461
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by RANGA c KRISHNA. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases IGC / IGC Pharma, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in IGC / IGC Pharma, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2012-08-07 IGC KRISHNA RANGA c 50,000 0.2000 50,000 0.2000 10,000 226 3.15 147,500 1,475.00
2012-07-12 IGC KRISHNA RANGA c 40,500 0.2300 40,500 0.2300 9,315
2011-10-14 IGC KRISHNA RANGA c 11,786 0.1800 11,786 0.1800 2,121
2011-10-11 IGC KRISHNA RANGA c 20,000 0.1700 20,000 0.1700 3,400
2011-10-10 IGC KRISHNA RANGA c 30,020 0.1700 30,020 0.1700 5,103
2011-10-07 IGC KRISHNA RANGA c 62,000 0.1700 62,000 0.1700 10,540
2011-10-04 IGC KRISHNA RANGA c 5,000 0.1700 5,000 0.1700 850
2011-10-03 IGC KRISHNA RANGA c 51,799 0.1800 51,799 0.1800 9,324
2011-09-30 IGC KRISHNA RANGA c 78,456 0.1800 78,456 0.1800 14,122
2011-09-29 IGC KRISHNA RANGA c 21,100 0.1900 21,100 0.1900 4,009
2011-09-28 IGC KRISHNA RANGA c 30,000 0.1900 30,000 0.1900 5,700
2011-09-26 IGC KRISHNA RANGA c 66,800 0.1900 66,800 0.1900 12,692
2011-09-20 IGC KRISHNA RANGA c 100,000 0.2000 100,000 0.2000 20,000
2011-08-10 IGC KRISHNA RANGA c 500,000 0.2300 500,000 0.2300 115,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IGC / IGC Pharma, Inc. Insider Trades
Insider Sales IGC / IGC Pharma, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in IGC / IGC Pharma, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IGC / IGC Pharma, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by RANGA c KRISHNA as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2012-09-07 2012-08-07 4 IGC India Globalization Capital, Inc.
India Gloabalization Inc
P - Purchase 50,000 1,068,461 4.91 0.20 10,000 213,692
2012-07-16 2012-07-12 4 IGC India Globalization Capital, Inc.
India Globalization
P - Purchase 40,500 1,018,461 4.14 0.23 9,315 234,246
2012-01-13 2011-10-14 4 IGC India Globalization Capital, Inc.
India Globalization Cap
P - Purchase 11,786 976,961 1.22 0.18 2,121 175,853
2012-01-13 2011-10-11 4 IGC India Globalization Capital, Inc.
India Globalization Cap
P - Purchase 20,000 965,175 2.12 0.17 3,400 164,080
2012-01-13 2011-10-10 4 IGC India Globalization Capital, Inc.
India Globalization Cap
P - Purchase 30,020 945,175 3.28 0.17 5,103 160,680
2012-01-13 2011-10-07 4 IGC India Globalization Capital, Inc.
India Globalization Cap
P - Purchase 62,000 915,155 7.27 0.17 10,540 155,576
2012-01-13 2011-10-04 4 IGC India Globalization Capital, Inc.
India Globalization Cap
P - Purchase 5,000 853,155 0.59 0.17 850 145,036
2012-01-13 2011-10-03 4 IGC India Globalization Capital, Inc.
India Globalization Cap
P - Purchase 51,799 848,155 6.50 0.18 9,324 152,668
2012-01-13 2011-09-30 4 IGC India Globalization Capital, Inc.
India Globalization Cap
P - Purchase 78,456 796,356 10.93 0.18 14,122 143,344
2012-01-13 2011-09-29 4 IGC India Globalization Capital, Inc.
India Gloabalization Cap
P - Purchase 21,100 717,900 3.03 0.19 4,009 136,401
2012-01-13 2011-09-28 4 IGC India Globalization Capital, Inc.
India Globalization Cap
P - Purchase 30,000 696,800 4.50 0.19 5,700 132,392
2012-01-13 2011-09-26 4 IGC India Globalization Capital, Inc.
India Globalization Cap
P - Purchase 66,800 666,800 11.13 0.19 12,692 126,692
2012-01-13 2011-09-20 4 IGC India Globalization Capital, Inc.
India Globalization Cap
P - Purchase 100,000 600,000 20.00 0.20 20,000 120,000
2012-01-13 2011-08-10 4 IGC India Globalization Capital, Inc.
India Gloabalization Cap
P - Purchase 500,000 500,000 0.23 115,000 115,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)